Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study.
British journal of cancer
View this publicationBritish journal of cancer
View this publicationHaematologica
View this publicationAllergy
View this publicationScientific reports
View this publicationNeuro-oncology advances
View this publicationCell reports
View this publicationJAMA
View this publicationEMBO molecular medicine
View this publicationEuropean journal of medical research
View this publicationScientific reports
View this publication